Report Detail
Global (United States, European Union and China) Nuclear Receptor ROR Gamma Market Research Report 2019-2025
- RnM3334654 |
- 21 April, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Nuclear Receptor ROR Gamma is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Receptor ROR Gamma.
This report studies the global market size of Nuclear Receptor ROR Gamma, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nuclear Receptor ROR Gamma sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Genfit SA
GlaxoSmithKline Plc
Aurigene Discovery Technologies Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Biogen Inc
AbbVie Inc
Advinus Therapeutics Ltd
Brickell Biotech Inc
Pfizer Inc
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd
Lead Pharma Holding BV
Market Segment by Product Type
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others
Market Segment by Application
Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Nuclear Receptor ROR Gamma status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nuclear Receptor ROR Gamma manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Nuclear Receptor ROR Gamma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Nuclear Receptor ROR Gamma Market Size Growth Rate by Type (2019-2025)
- 1.3.2 BBI-6000
- 1.3.3 GRC-39815Action
- 1.3.4 R&D Progress
- 1.3.5 GSK-2981278
- 1.3.6 IMU-366
- 1.3.7 INV-17
- 1.3.8 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Nuclear Receptor ROR Gamma Market Share by Application (2019-2025)
- 1.4.2 Chronic Obstructive Pulmonary Disease
- 1.4.3 Asthma
- 1.4.4 Axial Spondyloarthritis
- 1.4.5 Breast Cancer
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Nuclear Receptor ROR Gamma Market Size
- 2.1.1 Global Nuclear Receptor ROR Gamma Revenue 2014-2025
- 2.1.2 Global Nuclear Receptor ROR Gamma Sales 2014-2025
- 2.2 Nuclear Receptor ROR Gamma Growth Rate by Regions
- 2.2.1 Global Nuclear Receptor ROR Gamma Sales by Regions 2014-2019
- 2.2.2 Global Nuclear Receptor ROR Gamma Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Nuclear Receptor ROR Gamma Sales by Manufacturers
- 3.1.1 Nuclear Receptor ROR Gamma Sales by Manufacturers 2014-2019
- 3.1.2 Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Nuclear Receptor ROR Gamma Revenue by Manufacturers (2014-2019)
- 3.2.2 Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Nuclear Receptor ROR Gamma Market Concentration Ratio (CR5 and HHI)
- 3.3 Nuclear Receptor ROR Gamma Price by Manufacturers
- 3.4 Key Manufacturers Nuclear Receptor ROR Gamma Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Nuclear Receptor ROR Gamma Market
- 3.6 Key Manufacturers Nuclear Receptor ROR Gamma Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 BBI-6000 Sales and Revenue (2014-2019)
- 4.1.2 GRC-39815Action Sales and Revenue (2014-2019)
- 4.1.3 R&D Progress Sales and Revenue (2014-2019)
- 4.1.4 GSK-2981278 Sales and Revenue (2014-2019)
- 4.1.5 IMU-366 Sales and Revenue (2014-2019)
- 4.1.6 INV-17 Sales and Revenue (2014-2019)
- 4.1.7 Others Sales and Revenue (2014-2019)
- 4.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Type
- 4.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type
- 4.4 Nuclear Receptor ROR Gamma Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Nuclear Receptor ROR Gamma Sales by Application
6 United States
- 6.1 United States Nuclear Receptor ROR Gamma Breakdown Data by Company
- 6.2 United States Nuclear Receptor ROR Gamma Breakdown Data by Type
- 6.3 United States Nuclear Receptor ROR Gamma Breakdown Data by Application
7 European Union
- 7.1 European Union Nuclear Receptor ROR Gamma Breakdown Data by Company
- 7.2 European Union Nuclear Receptor ROR Gamma Breakdown Data by Type
- 7.3 European Union Nuclear Receptor ROR Gamma Breakdown Data by Application
8 China
- 8.1 China Nuclear Receptor ROR Gamma Breakdown Data by Company
- 8.2 China Nuclear Receptor ROR Gamma Breakdown Data by Type
- 8.3 China Nuclear Receptor ROR Gamma Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Company
- 9.2 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Type
- 9.3 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Application
- 9.4 Rest of World Nuclear Receptor ROR Gamma Breakdown Data by Countries
- 9.4.1 Rest of World Nuclear Receptor ROR Gamma Sales by Countries
- 9.4.2 Rest of World Nuclear Receptor ROR Gamma Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Genfit SA
- 10.1.1 Genfit SA Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.1.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.1.5 Genfit SA Recent Development
- 10.2 GlaxoSmithKline Plc
- 10.2.1 GlaxoSmithKline Plc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.2.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.2.5 GlaxoSmithKline Plc Recent Development
- 10.3 Aurigene Discovery Technologies Ltd
- 10.3.1 Aurigene Discovery Technologies Ltd Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.3.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.3.5 Aurigene Discovery Technologies Ltd Recent Development
- 10.4 Beijing Hanmi Pharmaceutical Co Ltd
- 10.4.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.4.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
- 10.5 Biogen Inc
- 10.5.1 Biogen Inc Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.5.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.5.5 Biogen Inc Recent Development
- 10.6 AbbVie Inc
- 10.6.1 AbbVie Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.6.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.6.5 AbbVie Inc Recent Development
- 10.7 Advinus Therapeutics Ltd
- 10.7.1 Advinus Therapeutics Ltd Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.7.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.7.5 Advinus Therapeutics Ltd Recent Development
- 10.8 Brickell Biotech Inc
- 10.8.1 Brickell Biotech Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.8.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.8.5 Brickell Biotech Inc Recent Development
- 10.9 Pfizer Inc
- 10.9.1 Pfizer Inc Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.9.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.9.5 Pfizer Inc Recent Development
- 10.10 Phenex Pharmaceuticals AG
- 10.10.1 Phenex Pharmaceuticals AG Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Nuclear Receptor ROR Gamma
- 10.10.4 Nuclear Receptor ROR Gamma Product Introduction
- 10.10.5 Phenex Pharmaceuticals AG Recent Development
- 10.11 Reata Pharmaceuticals Inc
- 10.12 Bristol-Myers Squibb Company
- 10.13 Celgene Corp
- 10.14 Eli Lilly and Company
- 10.15 Glenmark Pharmaceuticals Ltd
- 10.16 Lead Pharma Holding BV
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Nuclear Receptor ROR Gamma Sales Channels
- 11.2.2 Nuclear Receptor ROR Gamma Distributors
- 11.3 Nuclear Receptor ROR Gamma Customers
12 Market Forecast
- 12.1 Global Nuclear Receptor ROR Gamma Sales and Revenue Forecast 2019-2025
- 12.2 Global Nuclear Receptor ROR Gamma Sales Forecast by Type
- 12.3 Global Nuclear Receptor ROR Gamma Sales Forecast by Application
- 12.4 Nuclear Receptor ROR Gamma Forecast by Regions
- 12.4.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Regions 2019-2025
- 12.4.2 Global Nuclear Receptor ROR Gamma Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Receptor ROR Gamma. Industry analysis & Market Report on Nuclear Receptor ROR Gamma is a syndicated market report, published as Global (United States, European Union and China) Nuclear Receptor ROR Gamma Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nuclear Receptor ROR Gamma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
